BIO-key International, Inc. (NASDAQ:BKYI) Short Interest Down 40.7% in July

BIO-key International, Inc. (NASDAQ:BKYI) was the target of a significant decrease in short interest in July. As of July 31st, there was short interest totalling 12,100 shares, a decrease of 40.7% from the July 15th total of 20,400 shares. Currently, 0.8% of the company’s stock are sold short. Based on an average daily volume of 11,100 shares, the days-to-cover ratio is presently 1.1 days.

BIO-key International Stock Down 7.6 %

Shares of BKYI stock traded down $0.11 during trading on Thursday, hitting $1.29. 9,256 shares of the company were exchanged, compared to its average volume of 69,910. The business’s 50-day simple moving average is $1.59 and its 200 day simple moving average is $1.77. BIO-key International has a twelve month low of $1.25 and a twelve month high of $12.42. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.55 and a current ratio of 0.68.

BIO-key International (NASDAQ:BKYI) last issued its earnings results on Friday, June 14th. The technology company reported ($0.32) earnings per share (EPS) for the quarter. BIO-key International had a negative net margin of 96.03% and a negative return on equity of 340.45%. The company had revenue of $2.18 million for the quarter.

BIO-key International Company Profile

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.